SM03, a non-depleting anti-CD22 antibody, modulates B cell activation and immune crosstalk to attenuate autoimmunity.
- DOI
- 10.1016/j.jtauto.2026.100380
- Published
- 2026 Dec
- Container
- Journal of translational autoimmunity
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtauto.2026.100380,
title = {SM03, a non-depleting anti-CD22 antibody, modulates B cell activation and immune crosstalk to attenuate autoimmunity.},
author = {Wong KL and Cheng LH and Chung CL and Ng PL and Nawabjan SA and Sethuraman MIG and Luk KK and Tsoi WT and Chow BKC and Leung SO},
year = {2026},
journal = {Journal of translational autoimmunity},
doi = {10.1016/j.jtauto.2026.100380},
url = {https://doi.org/10.1016/j.jtauto.2026.100380}
}RIS
TY - JOUR TI - SM03, a non-depleting anti-CD22 antibody, modulates B cell activation and immune crosstalk to attenuate autoimmunity. AU - Wong KL AU - Cheng LH AU - Chung CL AU - Ng PL AU - Nawabjan SA AU - Sethuraman MIG AU - Luk KK AU - Tsoi WT AU - Chow BKC AU - Leung SO PY - 2026 JO - Journal of translational autoimmunity DO - 10.1016/j.jtauto.2026.100380 UR - https://doi.org/10.1016/j.jtauto.2026.100380 ER -
APA
KL, W., LH, C., CL, C., PL, N., SA, N., MIG, S., KK, L., WT, T., BKC, C., & SO, L. (2026). SM03, a non-depleting anti-CD22 antibody, modulates B cell activation and immune crosstalk to attenuate autoimmunity.. Journal of translational autoimmunity. https://doi.org/10.1016/j.jtauto.2026.100380
Source records
- pubmed · retrieved 2026-11-10T12:15:31.496Z
- europe-pmc · retrieved 2026-11-10T12:15:31.501Z